AWAP
PFE icon

Alliance Wealth Advisors (Pennsylvania)’s Pfizer PFE Stock Holding History

Alliance Wealth Advisors (Pennsylvania)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Sell
22,343
-628
-3% -$16.4K 0.17% 83
2026
Q1 		$645K Buy
22,971
+333
+1% +$8.87K 0.28% 56
2025
Q4 		$564K Sell
22,638
-1,666
-7% -$42K 0.25% 64
2025
Q3 		$619K Buy
24,304
+562
+2% +$13.9K 0.28% 60
2025
Q2 		$576K Buy
23,742
+261
+1% +$6.09K 0.29% 58
2025
Q1 		$595K Sell
23,481
-2,708
-10% -$70.9K 0.34% 52
2024
Q4 		$695K Sell
26,189
-2,772
-10% -$75.2K 0.39% 52
2024
Q3 		$838K Buy
28,961
+98
+0.3% +$2.86K 0.48% 40
2024
Q2 		$808K Buy
28,863
+3,589
+14% +$98.8K 0.51% 38
2024
Q1 		$701K Buy
25,274
+4,350
+21% +$121K 0.44% 45
2023
Q4 		$602K Sell
20,924
-1,635
-7% -$49.4K 0.4% 48
2023
Q3 		$748K Buy
22,559
+5,579
+33% +$197K 0.54% 40
2023
Q2 		$623K Buy
16,980
+1,012
+6% +$39.4K 0.44% 48
2023
Q1 		$651K Sell
15,968
-170
-1% -$7.34K 0.49% 44
2022
Q4 		$827K Sell
16,138
-505
-3% -$24.2K 0.69% 34
2022
Q3 		$728K Sell
16,643
-123
-0.7% -$5.98K 0.68% 35
2022
Q2 		$879K Sell
16,766
-103
-0.6% -$5.25K 0.76% 32
2022
Q1 		$873K Sell
16,869
-8,026
-32% -$416K 0.72% 36
2021
Q4 		$1.47M Sell
24,895
-5,378
-18% -$266K 1.2% 24
2021
Q3 		$1.3M Sell
30,273
-688
-2% -$30.5K 1.15% 25
2021
Q2 		$1.21M Sell
30,961
-376
-1% -$14.6K 1.09% 27
2021
Q1 		$1.14M Buy
31,337
+3,024
+11% +$107K 1.12% 26
2020
Q4 		$1.04M Buy
+28,313
New +$1.04M 1.09% 29

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alliance Wealth Advisors (Pennsylvania)'s PFE Position: Q2 2026 in Review

Alliance Wealth Advisors (Pennsylvania) reduced its Pfizer (PFE) stake by 2.7% in Q2 2026, selling an estimated $16.4K and leaving 22,343 shares worth $538K. The position accounts for 0.17% of the portfolio, ranked #83.

Alliance Wealth Advisors (Pennsylvania) first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.47M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Alliance Wealth Advisors (Pennsylvania) held 22,343 shares of Pfizer worth $538K as of Q2 2026.
  • Alliance Wealth Advisors (Pennsylvania) sold 628 Pfizer shares in Q2 2026, an estimated $16.4K.
  • Pfizer made up 0.17% of Alliance Wealth Advisors (Pennsylvania)'s portfolio in Q2 2026, its #83 holding.
  • Alliance Wealth Advisors (Pennsylvania) first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Alliance Wealth Advisors (Pennsylvania)'s Pfizer position peaked at $1.47M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Alliance Wealth Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 9 Jul 2026.